| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |